Shockwave (SWAV) Reports IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years
Go back to Shockwave (SWAV) Reports IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years| SWAV Enterprises Ltd. (NASDAQ: SWAV) | Delayed: 334.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $334.75 | 52 Week High | $0.06 | |||
| Open | $32.98 | 52 Week Low | $0.06 | |||
| Day High | $334.75 | P/E | N/A | |||
| Day Low | $334.75 | EPS | $0.00 | |||
| Volume | 2,444 | |||||
